Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Vn mi trng, thc phm, li sng hin ti lm c th ca bn khng th no chng li cc tc hi tim n nh hng nghim trng cho ln da v sc khe Bn n chay, n khng cht cng lm bn cn vin ung NOW Glutathione 500mg hn bao gi ht
Apple Cider Vinegar acts as a Natural Detox
Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier
Melanotan 2 is supplied as a lyophilised powder and reconstituted in the lab with bacteriostatic water
Key Points Animal studies suggest that endogenous, central glucagon-like peptide 1 (GLP-1) regulates both short-term and long-term energy balance, potentially via activation of hindbrain and hypothalamic GLP-1 receptors (GLP1R), respectively Endogenous peripheral GLP-1 may limit meal size by activation of GLP1R on local vagal afferent nerves and stimulation of a gutbrain feedback loop Increasing GLP1R activity by administering GLP-1 receptor agonists reduces food intake and promotes weight loss in humans, but the extent to which endogenous GLP-1 regulates energy balance in humans remains unknown Although diabetes mellitus and obesity appear to be associated with altered GLP-1 system activity, GLP1R agonists retain their efficacy in these contexts, making them a viable therapeutic tool A better understanding of how endogenous central and peripheral GLP-1 regulate energy balance has the potential to maximize our application of GLP-1-based therapies for the treatment of obesity This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access $189.00 per year only $15.75 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
